Real-World Long-Term Experience on Endoxifen in Bipolar Disorder with Psychotic Symptoms

Evidence suggests that inhibition of protein kinase C (PKC) signalling may have a contributing role in the treatment of bipolar affective disorder (BPAD). Endoxifen, an active metabolite of tamoxifen, is a potent direct PKC inhibitor. This report presents a severe case of a BPAD patient with a basel...

Descripción completa

Detalles Bibliográficos
Autor principal: Thanvi, Vikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271003/
https://www.ncbi.nlm.nih.gov/pubmed/35818415
http://dx.doi.org/10.1155/2022/3684181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271003/
https://www.ncbi.nlm.nih.gov/pubmed/35818415
http://dx.doi.org/10.1155/2022/3684181

Ejemplares similares